Beware of a black cat that crosses your path - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

Beware of a black cat that crosses your path

Description:

On day 9 of admission a right Austin Moore hemiarthroplasty is performed with ... She is still in the ICU on day 72 of admission ... – PowerPoint PPT presentation

Number of Views:42
Avg rating:3.0/5.0
Slides: 41
Provided by: fionaal
Category:
Tags: beware | black | cat | crosses | path

less

Transcript and Presenter's Notes

Title: Beware of a black cat that crosses your path


1
Beware of a black cat that crosses your path
Case 2 Prevention
2
History
  • 78 year old female
  • Tripped over her cat at the top of the stairs
  • Presented to the Emergency Department complaining
    of pain in her right leg
  • No significant past medical history
  • Normally independent, fit and well
  • Lifelong non-smoker
  • Had been prescribed an anti-hypertensive agent in
    the past, but didnt take it

3
Examination
  • Shortened, externally rotated, painful right leg
  • Bruises on left arm and small laceration left
    shin
  • Afebrile, pulse 100 (regular), blood pressure
    120/70
  • Loud pansystolic murmur best heard at apex
  • Good air entry both lungs, O2 saturation 96 on
    air

4
What investigations would you perform?
  • Chest X-ray
  • Pelvis X-Ray
  • Transthoracic Echocardiogram
  • Full Blood Count
  • Urea and Electrolytes
  • All of the above

5
Initial X-Rays
6
Initial X-Rays
7
Results
  • FBC Hb 9.4 g/dL, wbc 11.9, plts 243 (x109/L)
  • UE Na 144, K 3.3, creatinine 47 µmol/L
  • CRP 9 mg/L (normal range 0-6)

8
Results
  • Echocardiogram report
  • Normal LV with hyperdynamic function
  • LA mildly dilated
  • MV leaflets sclerotic with dense echogenic mass
    at tip and moderate/severe mitral regurgitation
  • AV normal
  • Mild PV and TV regurgitation
  • Moderate to severe pulmonary hypertension

9
Follow-up
  • Surgery is delayed while the cardiac status is
    reviewed
  • Endocarditis is considered and eventually
    excluded on grounds of lack of clinical signs or
    inflammatory response and negative blood cultures
  • On day 9 of admission a right Austin Moore
    hemiarthroplasty is performed with flucloxacillin
    perioperative prophylaxis
  • The anaesthetic assessment notes that she is a
    high anaesthetic risk in view of her mitral valve
    disease and pulmonary hypertension

10
Follow-up
  • On day 16 of admission she becomes breathless.
    She is hypotensive (bp 90/60) and has a fever of
    38ºC.
  • On examination she is found to be in fast atrial
    fibrillation and to have reduced air entry at the
    right lung base.
  • Benzylpenicillin and ciprofloxacin are commenced

11
Results
  • CRP 235 mg/L (normal 0-6)
  • FBC Hb 10.9 g/dL
  • wbc 17.3 x 109/L (normal 4-11)
  • neutrophils 12.8 x 109/L (normal 2-7.5)
  • lymphocytes 1.0 x 109/L (normal 1.5-4)
  • monocytes 2.9 x 109/L (normal 0.2-0.8)
  • Film comment occasional reactive lymphocyte seen

12
Chest X-Ray Day 16
13
Follow-up
  • On day 17 of admission she is sweaty and clammy.
  • Her respiratory rate is 42/minute and her O2
    saturation 86 on air. She has widespread wheeze
    and crackles throughout both lungs
  • The medical registrar considers that she is
    clearly septic and she is transferred to the ICU

14
What would you do next?
  • Ensure that she is in a side room with negative
    pressure ventilation?
  • Perform bronchoscopy and bronchoalveolar lavage
    (BAL)?
  • Provide ventilatory support?
  • Change antibiotic therapy?

15
Follow-up
  • On admission to the ICU she is noted to have a
    fruity cough and bronchial breathing at both
    lung bases
  • She has a temperature of 37.5ºC and her O2
    saturation is 85 on 90 humidified oxygen. She
    is cardioverted into sinus rhythm and given
    inotrope support
  • A diagnosis of pulmonary oedema and sepsis is
    made. Respiratory tract infection is considered
    the most likely source

16
What antibiotic regimen (if any) would you
prescribe initially?
  • Continue benzylpenicillin and ciprofloxacin
  • Carbapenem alone
  • Carbapenem plus glycopeptide
  • Betalactam/cephalosporin alone
  • Betalactam/cephalosporin plus glycopeptide
  • Betalactam/cephalosporin plus macrolide
  • Other

17
Initial tests and treatment
  • BAL immunofluorescence positive for
    parainfluenzavirus type 3 on two separate
    specimens taken on consecutive days
  • Bacterial cultures are all negative

18
What would you do next?
  • Ensure that she is in a side room with negative
    pressure ventilation?
  • Change antibiotic therapy?
  • Continue current management?
  • Other?

19
Follow-up
  • She is breathing without ventilatory support
    until day 19 of her admission when she becomes
    very tired and finally is intubated
  • On initial ICU admission benzylpenicillin plus
    ciprofloxacin are continued. These are stopped
    after 5 days in view of the BAL findings
  • She is moved into a side room with negative
    pressure ventilation to prevent spread of
    parainfluenzavirus type 3 to other patients

20
Chest X-Ray Day 21
21
Follow-up
  • After initial improvement between day 21 and day
    28 of admission she is noted to have a fever of
    38ºC and increasing production of thick brownish
    sputum
  • The white cell count is raised at 13.4 x 109/L
    and the CRP is high, but little changed at 93
    mg/L
  • Bronchoscopy reveals numerous plugs of mucus in
    the right middle and lower lobe

22
Chest X-Ray Day 28
23
CT Scan Day 29
Bilateral pleural effusions
24
What is your diagnosis?
25
What antibiotic regimen (if any) would you
prescribe?
  • Quinolone alone
  • Quinolone plus glycopeptide
  • Carbapenem alone
  • Carbapenem plus glycopeptide
  • Betalactam/cephalosporin alone
  • Betalactam/cephalosporin plus glycopeptide
  • Betalactam/cephalosporin plus macrolide
  • Other

26
Subsequent tests
  • BAL
  • Numerous pus cells seen on microscopy
  • Culture Klebsiella pneumoniae gt105 cfu/mL
  • Resistant to ampicillin, ciprofloxacin,
    gentamicin, cefotaxime and ceftazidime
    (ESBL-positive)
  • Susceptible to meropenem

27
Follow-up
  • She is treated with vancomycin and meropenem for
    10 days and makes a slow improvement
  • Bronchoscopy is repeated on three occasions to
    remove mucus plugs
  • She is slowly weaned onto non-invasive
    ventilation (NIPPV), but makes very slow progress
  • She is still in the ICU on day 72 of admission

28
What do you consider to be the key issues in this
case?
  • Why did this lady develop pneumonia?
  • What else could have been done?

29
Key issues
30
Prevention Four broad categories
  • General
  • Equipment
  • Patient procedures
  • Environmental issues

31
I - General issues
Vaccination
Education guidelines
Hand hygiene and other infection control practices
32
II Equipment maintenance and disinfection
Ventilator humidifiers and circuits
33
III Patient procedures
Line insertion
34
IV Environmental issues
Building work, fungal prophylaxis, environmental
sampling
35
Grade A Recommendations (1)
  • Care protocols and guidelines for weaning and
    sedation should be developed and actively
    followed in the critical care setting to reduce
    the incidence of VAP
  • Changing ventilator circuits before seven days is
    of no benefit
  • Daily changes of suction equipment are not
    required

36
A Recommendations (2)
  • Heat moisture exchangers (HMEs) are more
    effective in reducing the incidence of VAP
    compared to HHs (heated humidifiers) provided
    there are no contraindications to their use (e.g.
    patients at risk of airways obstruction)
  • Where HMEs are used (except with high minute
    volume) these should not be changed routinely
    but manufacturers guidance should be followed

37
A Recommendations (3)
  • Non-invasive ventilation (NIV) rather than
    mechanical ventilation should be used in selected
    patients to reduce the risk of HAP
  • The decisions on the method of enteral feeding to
    be used for critically ill patients should be
    made locally by each unit and on an individual
    patient basis
  • Physiotherapists and respiratory therapist have a
    role in preventing respiratory complications in
    post-operative ventilated patients

38
A Recommendations (4)
  • Whenever clinically appropriate stress ulcer
    prophylaxis should be avoided in order to help
    preserve gastric function
  • Where stress ulcer prophylaxis is indicated,
    sucralfate is to be preferred in order to reduce
    the risk of VAP
  • Sucralfate should only be used in patients with
    low to moderate risk of gastro-intestinal
    bleeding

39
B Recommendations (1)
  • Hospital education programmes should form part of
    the risk reduction measures for HAP as part of an
    overall infection control strategy
  • New ventilator circuit tubing should be provided
    for each patient
  • Closed and open suctioning systems can be used
    without affecting the risk of VAP
  • Measures should be taken to reduce the risk of
    aspiration to prevent VAP
  • If a patient does not require supine positioning
    consideration should be given to using
    semi-recumbent positioning as a strategy to
    prevent VAP

40
B Recommendations (2)
  • Appropriate Legionella control of hospital water
    is required
  • During building works, consideration must be
    given to addressing the risk of pulmonary
    aspergillosis. This must include
  • Identifying high risk patients
  • Methods to reduce all patients exposure to
    aspergillus e.g. use of floor to ceiling
    barriers, sealing of windows
  • The use of HEPA filtration in high risk units
  • e.g. HSCT units, ICU
  • Dust reduction in clinical areas
Write a Comment
User Comments (0)
About PowerShow.com